Research and development

View Life Sciences by content type:

Latest Life Sciences News

Featured Life Sciences content

Practice notes
Rome II—application and interpretationThis Practice Note is for use when determining applicable law in respect of events giving rise to damage, where...
Read More >
19th May
Q&As
Can a third party rely on ostensible/apparent authority where they know the person signing a document is an employee of a company not a director and...
Read More >
19th May
Practice notes
Brexit—exiting the EU under Article 50 [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note contains...
Read More >
Produced in partnership with Adam Cygan of University of Leicester 19th May
Practice notes
Antibiotic drug Nitrofurantoin (AMCo, Morningside Healthcare, Morningside Pharmaceuticals and Alliance Healthcare) (50507)CASE HUB See further,...
Read More >
19th May
Q&As
Can the board of a co-operative and community benefit society (a registered society) delegate powers to any third party, and can the registered...
Read More >
19th May
Practice notes
Rome Convention—introduction and interpretation [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.The UK is no longer...
Read More >
19th May
Precedents
Coronavirus (COVID-19): In addition to the below content on force majeure generally, see also: • Coronavirus (COVID-19)...
Read More >
19th May
Practice notes
Many companies and government bodies (such as HMRC) have been exposed to loss of confidential information and many other breaches of confidentiality...
Read More >
19th May
Practice notes
Introduction to retained EU lawThis Practice Note provides an introduction to retained EU law. It provides an overview of the key definitions and...
Read More >
Produced in partnership with Dr. Kieran Laird of Gowling WLG 19th May
Precedents
1 Counterparts—agreement 1.1 This agreement may be signed in any number of separate counterparts, each of which when...
Read More >
19th May
Practice notes
Model ADR clausesThis Practice Note considers model form alternative dispute resolution (ADR) clauses provided by a number of service providers,...
Read More >
19th May
Precedents
Option 1—contract signed on behalf of a company, where the authorised signatory is an individual Signed by [insert name of...
Read More >
19th May
Practice notes
Requirements of the company sealThis Practice Note provides practical guidance regarding the requirements of the company seal. Where a company has a...
Read More >
19th May
Practice notes
Brexit implementation period—enforcement [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note considers...
Read More >
19th May
Practice notes
SubcontractingThis Practice Note examines the following legal and practical matters in relation to entering into a subcontract or when granting...
Read More >
19th May
Practice notes
ScopeThis Practice Note explains trade mark law on parallel trade. Parallel imports, or ‘grey market’ goods, are genuine goods that are placed on the...
Read More >
Produced in partnership with Taylor Wessing LLP 19th May

Most recent Research and development content

Precedents
Confidentiality agreement—mutualThis Agreement is made on [date]Parties1[insert name of party] [of [insert details ] OR a company incorporated in...
Read More >
26th Jul
Precedents
Clinical Research Organisation (CRO) master services agreementIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit...
Read More >
25th Jul
Precedents
Collaboration agreementIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered into...
Read More >
25th Jul
Practice notes
Know-how—protection and licensingThis Practice Note explains what know-how is and sets out the different ways know-how can be protected before...
Read More >
25th Jul
Practice notes
What does IP completion day mean for clinical trials?11 pm (GMT) on 31 December 2020 marked the end of the implementation period put in place to...
Read More >
25th Jul
Precedents
Confidentiality agreement—one-way—pro-recipientThis Agreement is made on [date]Parties1[Insert name of party] [of [insert address] OR a company...
Read More >
25th Jul
Precedents
Confidentiality letter—mutual[insert address of sender]Our ref: [insert reference]Your ref: [insert reference][Insert address of recipient]Date:...
Read More >
25th Jul
Precedents
Research and development agreement (long form)IP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation...
Read More >
25th Jul
Precedents
Material transfer agreementIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered into...
Read More >
Produced in partnership with Patricia Barclay of Bonaccord 25th Jul
Practice notes
Access to documents and information on medicinal products in the EUIn recent years, we have witnessed a constantly growing interest from all...
Read More >
Produced in partnership with Vincenzo Salvatore of BonelliErede 25th Jul
Precedents
Confidentiality letter—one-way—pro-discloser[insert address of sender]Our ref: [insert reference]Your ref: [insert reference][insert address of...
Read More >
25th Jul
Precedents
Confidentiality letter—one-way—pro-recipient[insert address of sender]Our ref: [insert reference]Your ref: [insert reference][insert address of...
Read More >
25th Jul
Practice notes
Clinical trialsThe purpose of clinical trialsA clinical trial is an investigation conducted in human subjects which aims to discover or verify the...
Read More >
25th Jul
Precedents
Confidentiality agreement—one-way—pro-discloserThis Agreement is made on [date]Parties1[Insert name of party][ of [insert details] OR a company...
Read More >
Produced in partnership with Gateley 25th Jul
Practice notes
The EU Clinical Trials RegulationNew EU regulation on clinical trialsThis Practice Note covers the new Regulation (EU) 536/2014 on clinical trials,...
Read More >
Produced in partnership with Eveline Van Keymeulen of Allen & Overy and Marco de Morpurgo 25th Jul
Practice notes
Introduction to technology transfer agreements in the Life Sciences industryWhat is a technology transfer agreement?The term ‘technology transfer...
Read More >
Produced in partnership with Thomas Bjorn 25th Jul
Q&As
Is a pharmaceutical company sponsor of a clinical trial obliged to provide access to the trial medicine free of charge once the trial is...
Read More >
25th Jul
Precedents
EU Clinical Trials Regulation—training materialsThese training materials consist of template PowerPoint slides that can be used as the basis of one or...
Read More >
28th Jun
Q&As
Which laws and regulations govern health care apps (mHealth)?Regulation as a medical deviceAn app may, depending on the specific characteristics and...
Read More >
6th Jun
Q&As
What are the implications for an insured who participates in clinical trials but fails to notify his insurers of any existing health conditions or...
Read More >
Produced in partnership with Julia Dias QC of 7KBW 6th Jun

Popular documents